Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

BACKGROUND: Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet
Hlavní autoři: Parker, Chris C, Clarke, Noel W, Cook, Adrian D, Kynaston, Howard, Catton, Charles N, Cross, William R, Petersen, Peter M, Persad, Rajendra A, Saad, Fred, Bower, Lorna C, Logue, John, Payne, Heather, Forcat, Silvia, Goldstein, Cindy, Murphy, Claire, Anderson, Juliette, Barkati, Maroie, Bottomley, David M, Branagan, Jennifer, Choudhury, Ananya, Chung, Peter W M, Cogley, Lyn, Goh, Chee L, Hoskin, Peter, Khoo, Vincent, Malone, Shawn C, Masters, Lindsey, Morris, Stephen L, Nabid, Abdenour, Ong, Aldrich D, Raman, Rakesh, Tarver, Kathryn L, Tree, Alison C, Worlding, Jane, Wylie, James P, Zarkar, Anjali M, Parulekar, Wendy R, Parmar, Mahesh K B, Sydes, Matthew R
Médium: Artigo
Jazyk:Inglês
Vydáno: 2024
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616360/
https://ncbi.nlm.nih.gov/pubmed/38763154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(24)00548-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky